Male pattern baldness is a common condition that is often treated by hair transplant surgery. In this procedure hair follicles from areas of the scalp that are not within the baldness pattern are excised and re-implanted to create the illusion of a fuller head of hair. In fact, no new hair is created by this procedure, which is limited by the number of follicles that can be harvested for re-distribution. Thus, there is a great need, satisfied by the present invention, for a means for stimulating the growth of multiple new hair follicles in the scalp of an individual.
This invention relates to new bioabsorbable scaffolds that are useful for the tissue engineering of new hair follicles and to methods for their manufacture and to methods of their use in creating new hair. More specifically it relates to new and useful bioabsorbable porous structures that have the correct architecture to facilitate culturing of the appropriate follicle progenitor cells and their development into normal, functional, hair-producing follicles. The invention also relates to methods of making and using bioabsorbable scaffolds to implant and grow new hair follicles in vitro and in vivo.
In one aspect, the present invention comprises porous bioabsorbable scaffolds that are in the approximate shape of the normal hair follicle bulb, and designed to promote the formation of a hair follicle when seeded with hair follicle cells and implanted intradermally into a living host.
The scaffolds of the present invention are preferably comprised of a bioabsorbable polymer, selected from any of a wide variety of synthetic and natural polymers that are commonly used in clinical practice and in biomedical research. The scaffolds are more preferably comprised of a polymer selected from the group consisting of poly(lactic acid), poly(glycolic acid), poly(trimethylene carbonate), poly(amino acid)s, tyrosine-derived poly(carbonate)s, poly(carbonate)s, poly(caprolactone), poly(para-dioxanone), poly(ester)s, poly(ester-amide)s, poly(anhydride)s, poly(ortho ester)s, poly(amino acid)s, collagen, gelatin, serum albumin, proteins, carbohydrates, poly(ethylene glycol)s, poly(propylene glycol)s, poly(acrylate ester)s, poly(methacrylate ester)s, poly(vinyl alcohol), and copolymers, blends and mixtures of said polymers.
When the scaffold is comprised of a synthetic polymer, it is preferably a synthetic polymer formed from any one or combination of the following monomers: L-lactide, d,l-lactide, glycolide, trimethylene carbonate, caprolactone, and para-dioxanone. Other preferred synthetic polymers for use in making the scaffold of the present invention include poly(ethylene glycol), poly(vinyl alcohol), poly(acrylic acid) and other water soluble polymers that have been crosslinked with degradable linkages and any bioabsorbable hydrogel that has been modified to support cell attachment.
When the scaffold is comprised of a crosslinked or otherwise insoluble or insolubilized naturally occurring polymer, it is preferably a polymer selected from the group consisting of hyaluronic acid, human serum albumin, collagen, gelatin, cellulose derivatives, starch, dextrin, chitosan, and other proteins, glycoproteins, lipoproteins, polysaccharides, and biopolymers.
A preferred scaffold of the present invention has an inner surface which is preferably in the shape of the outer surface of a hair root or bulb. The inner surface of the scaffold is preferably porous. The porosity of the scaffold is preferably sufficient to enable hair follicle cells to be adsorbed by the inner surface of the scaffold when placed into contact therewith, e.g., in a cell culture solution.
Methods of making the porous bioabsorbable scaffolds of the present invention are disclosed herein, below. Such methods include procedures for creating porosity in bioabsorbable materials and procedures for molding, shaping, or sculpting said porous scaffolds into the desired configuration. The present invention is not limited to scaffolds produced according to the specific methods disclosed herein, below, as it is contemplated that the scaffolds could be made using variations of the disclosed methods, or by adapting known means used to manufacture porous polymers.
Any one of a number of different means are suitable for creating the porosity of the scaffolds of the present invention. A preferred method for creating porosity involves the use of “blowing agents”. These are chemical additives that decompose at known temperatures with the liberation of gases that cause foaming in the molten polymer and porosity in the resultant cooled material. A number of useful blowing agents are commercially available under the trade name of Celogen™ (Uniroyal Chemical Co.). One example of a traditional blowing agent is azodicarbonamide. Another blowing agent that may be especially useful in the present invention due to its compatibility with bioabsorbable polymers is urea dicarboxylic acid anhydride, described in U.S. Pat. No. 4,104,195, the teachings of which are incorporated herein. The use of blowing agents can produce both open cell and closed cell foams. In the present invention open cells are desired and closed cells are to be avoided. Thus the conditions used in the manufacture of the porous coating are preferably optimized to achieve an open cell structure known as “reticulated” foam. The porosity of the scaffold is preferably due to interconnected pores in the size range of 0.1 to 1,000 microns, more preferably in the size range of 1 to 500 microns.
In an alternative embodiment, the porosity of the scaffold is due to the fact that the scaffold has a fibrous structure. When the scaffold has a fibrous structure, the fibers are preferably bonded together. The fibers of such a preferred structure are more preferably comprised of a core and sheath structure, said sheath being lower melting than said core, and bonded together by means of inter-fiber welds in the sheaths at points of contact.
One preferred method of making a scaffold of the present invention, (hereinafter, “the dissolution method”) comprises the following steps:
The dissolution method is illustrated in
Examples of materials that can be used to create the form and solvents that can be selected for use as solvent B in the dissolution method, described above, include the following combinations: poly(ethylene oxide) and water; paraffin wax and hexane; and polystyrene and acetone. The pore forming substance and form material must be selected from those substances that have low solubility in solvent A, used to introduce the bioabsorbable polymer into the structure. These choices are further exemplified in Table 1 below where the following abbreviations have been used: PLGA is a copolymer of lactic and glycolic acids and PEO is poly(ethylene oxide).
A modification of the dissolution method is exemplified by reversing the sequence of steps of creating the desired structure followed by seeding with progenitor cells. Thus a porous scaffold structure can first be formed in the shape of a disc, for example by adding a solution of polymer in an organic solvent to appropriately sized salt particles in a cylindrical container followed by evaporation of said solvent and removal of the salt by dissolving and rinsing with water.
The resultant highly porous scaffold can then be sterilized and seeded with micro-dissected human dermal papilla or other suitable source of follicle progenitor cells and cultured in vitro until the entire porous structure is populated with cultured cells. This tissue-engineered construct then can be cut up into a large number of fragments, each about the size of a normal human dermal papilla. These irregular shaped fragments can be suspended in culture media and cultured further until the desired smooth surfaced structure is obtained. These tissue engineered dermal papilla can be implanted or injected into the skin to initiate the process of follicle neogenesis for hair restoration.
Alternatively, the porous scaffolds of the present invention can also be made according to the following method (hereinafter, the “pressed mold method”), comprising the following steps:
1. Provide a thin, non-woven web of bioabsorbable fibers.
2. Place said web in a two-part mold that has cavities in one part and mating forms in the other part, said cavities and forms providing the desired shape and dimensions of the desired scaffolds.
3. Close the mold and apply sufficient heat and pressure to form the web into the desired porous structure.
4. Remove the web from the mold and die-cut the molded scaffolds from the web.
The non-woven web preferably comprises either fibers that have a core/sheath structure in which the core of the fiber has a higher melting temperature than the sheath, or fibers without such a structure. The fibers in the non-woven web are preferably felted, sintered, or bonded with the use of a solvent or a second polymer dissolved in a solvent.
The mold production process described immediately above is particularly well suited for scale-up and mass production. For example, the two-part mold shown in
Other methods of creating porous scaffolds from bioabsorbable materials also can be used in practice of the present invention. Methods such as emulsion freeze-drying, expansion in high pressure gas, 3D printing, and phase separation techniques are discussed in an article by Y. S. Nam and T. G. Park, “Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation”, The Journal of Biomedical Materials Research, October 1999, vol. 47, no. 1, pages 8–17, the teachings of which are incorporated herein.
A preferred embodiment of the above-mentioned phase separation technique uses poly(d,l-lactide-co-glycolide) (PLGA) as the structural polymer and poly(ethylene glycol) (PEG) as the porogen. Thus a mixture of PLGA and PEG can be dissolved in dichloromethane to give a clear solution, which is then applied to a scaffold form made from a material that is not soluble in dichloromethane, but preferably soluble in water, for example sugar. Upon evaporation of the dichloromethane, the PEG phase separates from the PLGA by crystallization. If the form is made of sugar, then soaking in water dissolves out the PEG as well as the form to leave the resultant desired porous PLGA scaffold.
Scaffolds of the present invention can be used to engineer new hair follicles in a number of ways. In general, the appropriate cells can be seeded on the scaffold and either implanted immediately into the scalp or allowed to multiply in culture on the scaffold prior to implantation. The implantation procedure can be the same technique that hair transplant surgeons currently use to implant single follicles or “mini-grafts”. For example, a laser can be used to bore a small hole in the scalp to precisely the desired depth and the cell-seeded scaffold can simply be planted in the hole. As these implanted cells grow they orchestrate the neo-genesis of a new hair follicle. The bioabsorbable scaffold then degrades and is eliminated from the site as the implant matures into a normal, hair-producing follicle.
The cells used to seed the scaffold can be taken from follicles biopsied from the patient or from organ donor follicles. This later option is known to be feasible due to recent research results. Follicle progenitor cells from a human donor were successfully transplanted into an unrelated human recipient where they initiated the formation of new follicles that grew hair. This finding, entitled “Trans-gender induction of hair follicles”, was reported by A. M. Reynolds, C. Lawrence, P. B. Caerhalmi-Friedman, A. M. Christiano and C. A. B. Jahoda in Nature, 402, 33–34, Nov. 4, 1999, the teachings of which are incorporated by reference herein. A distinct advantage of the present invention is the ability to multiply the cells in culture before seeding them on the scaffold implants. This both maximizes the number of scaffolds that can be seeded from each harvested follicle and minimizes the labor of dissecting follicles to obtain the desired progenitor cells.
Poly(ethylene oxide) (hereinafter, “PEO”) 100,000 molecular weight purchased from Aldrich Chemical Co. (Milwaukee, Wis. 53201), was melt extruded into a 1.0 mm diameter filament and cut into 2 cm lengths. One of the PEO filaments was dipped into water, hydrating the surface and making it sticky. This was then dipped into sodium chloride crystals that had been ground into fine particles in an electric coffee bean grinder. Excess salt was shaken off and the coating was allowed to dry. A 10% (w/v) solution of poly(d,l-lactide-co-50%-glycolide) (PLGA) (Resomer RG504, Boehringer Ingelheim, Germany) in acetone (Aldrich Chemical Co.) was dripped onto the salt encrusted PEO filament and the excess solution was allowed to run off. Additional powdered salt was sprinkled onto the surface until it was completely covered. After the acetone evaporated, the coated PEO filament was placed in water until all of the salt and PEO dissolved, leaving a hollow filament of porous PLGA which was removed, flattened, and cut into thin strips with a sharp blade. The strips were rolled between finger and thumb and cut into 2 mm lengths. The hollow filament of porous PLGA produced as described above was used to make a form for a scaffold of the present invention, as follows.
Scaffolds of the present invention were produced as follows. A 0.3 mm diameter concentric hole was made in the end of another PEO filament by pressing a heated needle about 2 mm into the PEO. This caused molten PEO to build up around the sides of the filament. Upon cooling, the needle was removed. The hole was then filled with one of the above rolled strips of porous PLGA. The end of the resulting PEO filament was then coated as described above with salt and PLGA solution. Upon evaporation of the acetone and dissolving all of the salt and PEO in water and drying, the desired porous bioabsorbable polymer scaffold was obtained.
Human hair follicles are dissected to obtain the dermal papilla, which are transferred to a culture flask containing culture media. After several weeks in culture, the dermal papilla cells multiply and grow over the surface of the cell culture flask. These cells are detached from the flask by treatment with an enzyme and concentrated by centrifugation. The cells are then transferred, after re-suspension, by pipette into the scaffolds of Example 1 and the cell-seeded scaffolds placed in a culture flask with media for several days to allow the cells to adhere to the surfaces of the scaffolds. Culturing of the cell-seeded scaffolds is then continued in another flask of media with gentle stirring until the scaffolds are fully populated with cells.
Scaffolds seeded as described in Example 2 are implanted into the scalp of a human experiencing hair loss. Over time, as new hair follicles are created, new hairs grow from the implants, and the scaffolds bioabsorb.
This application claims priority to PCT/US01/24671 filed Aug. 7, 2001, which claims priority to U.S. Provisional Patent Application No. 60/223,636 filed Aug. 8, 2000, all of which are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US01/24671 | 8/7/2001 | WO | 00 | 7/14/2003 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO02/15952 | 2/28/2002 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2946769 | Rose et al. | Jul 1960 | A |
3025323 | Rose et al. | Mar 1962 | A |
3596292 | Erb et al. | Aug 1971 | A |
3966766 | Lehn | Jun 1976 | A |
4052988 | Doddi et al. | Oct 1977 | A |
4104195 | Ley et al. | Aug 1978 | A |
4209607 | Shalaby et al. | Jun 1980 | A |
4226243 | Shalaby et al. | Oct 1980 | A |
4242931 | Clement | Jan 1981 | A |
4343931 | Barrows | Aug 1982 | A |
4384061 | Reiter et al. | May 1983 | A |
4429080 | Casey et al. | Jan 1984 | A |
4458678 | Yannas et al. | Jul 1984 | A |
4505266 | Yannas et al. | Mar 1985 | A |
4529792 | Barrows | Jul 1985 | A |
4604097 | Graves, Jr. et al. | Aug 1986 | A |
4643734 | Lin | Feb 1987 | A |
4719917 | Barrows et al. | Jan 1988 | A |
4851521 | della Valle et al. | Jul 1989 | A |
4919664 | Oliver et al. | Apr 1990 | A |
5061284 | Laghi | Oct 1991 | A |
5091173 | Buultjens et al. | Feb 1992 | A |
5133739 | Bezwada et al. | Jul 1992 | A |
5141522 | Landi | Aug 1992 | A |
5147400 | Kaplan et al. | Sep 1992 | A |
5194473 | Shinoda et al. | Mar 1993 | A |
5198507 | Kohn et al. | Mar 1993 | A |
5286837 | Barrows et al. | Feb 1994 | A |
5393323 | Simmons | Feb 1995 | A |
5403347 | Roby et al. | Apr 1995 | A |
5415378 | Craven | May 1995 | A |
5423778 | Eriksson et al. | Jun 1995 | A |
5486593 | Tang et al. | Jan 1996 | A |
5502092 | Suszko et al. | Mar 1996 | A |
5514378 | Cima et al. | May 1996 | A |
5522841 | Roby et al. | Jun 1996 | A |
5545208 | Wolff et al. | Aug 1996 | A |
5556783 | Lavker et al. | Sep 1996 | A |
5578046 | Liu et al. | Nov 1996 | A |
5599552 | Dunn et al. | Feb 1997 | A |
5611811 | Goldberg | Mar 1997 | A |
5639645 | Murata | Jun 1997 | A |
5661132 | Eriksson et al. | Aug 1997 | A |
5667961 | Bernard et al. | Sep 1997 | A |
5674286 | D'Alessio et al. | Oct 1997 | A |
5677355 | Shalaby et al. | Oct 1997 | A |
5690961 | Nguyen | Nov 1997 | A |
5697901 | Eriksson | Dec 1997 | A |
5697976 | Chesterfield et al. | Dec 1997 | A |
5721049 | Marcolongo et al. | Feb 1998 | A |
5723508 | Healy et al. | Mar 1998 | A |
5756094 | Lavker et al. | May 1998 | A |
5770417 | Vacanti et al. | Jun 1998 | A |
5847012 | Shalaby et al. | Dec 1998 | A |
5898040 | Shalaby et al. | Apr 1999 | A |
5919893 | Roby et al. | Jul 1999 | A |
5939323 | Valentini et al. | Aug 1999 | A |
5945115 | Dunn et al. | Aug 1999 | A |
5993374 | Kick | Nov 1999 | A |
5997468 | Wolff et al. | Dec 1999 | A |
5997568 | Liu | Dec 1999 | A |
6001378 | Desjonqueres | Dec 1999 | A |
6027744 | Vacanti et al. | Feb 2000 | A |
6031148 | Hayes et al. | Feb 2000 | A |
6051750 | Bell | Apr 2000 | A |
6093200 | Liu et al. | Jul 2000 | A |
6120788 | Barrows | Sep 2000 | A |
6147135 | Yuan et al. | Nov 2000 | A |
6159950 | Crystal et al. | Dec 2000 | A |
6303697 | Yuan et al. | Oct 2001 | B1 |
6333029 | Vyakarnam et al. | Dec 2001 | B1 |
6350284 | Tormala et al. | Feb 2002 | B1 |
6365172 | Barrows | Apr 2002 | B1 |
6383220 | van Blitterswijk et al. | May 2002 | B1 |
6423252 | Chun et al. | Jul 2002 | B1 |
6436424 | Vogel et al. | Aug 2002 | B1 |
6474344 | Yamada | Nov 2002 | B2 |
6503539 | Gestrelius et al. | Jan 2003 | B2 |
6511748 | Barrows | Jan 2003 | B1 |
6569143 | Alchas et al. | May 2003 | B2 |
6613798 | Porter et al. | Sep 2003 | B1 |
6639051 | Wang | Oct 2003 | B2 |
6660301 | Vogel et al. | Dec 2003 | B1 |
6699287 | Son et al. | Mar 2004 | B2 |
6773713 | Bonassar et al. | Aug 2004 | B2 |
6884427 | Barrows | Apr 2005 | B1 |
20020049426 | Butler et al. | Apr 2002 | A1 |
20020083216 | Hickson et al. | Jun 2002 | A1 |
20020193740 | Alachas et al. | Dec 2002 | A1 |
20020193778 | Alachas et al. | Dec 2002 | A1 |
20020197326 | Vogel et al. | Dec 2002 | A1 |
20030009113 | Olson | Jan 2003 | A1 |
20030072784 | Williams | Apr 2003 | A1 |
20030077311 | Vyakarnam et al. | Apr 2003 | A1 |
20030161815 | Wolowacz et al. | Aug 2003 | A1 |
20030195625 | Castro et al. | Oct 2003 | A1 |
20030203003 | Nelson et al. | Oct 2003 | A1 |
20030208138 | Olson | Nov 2003 | A1 |
20030211083 | Vogel et al. | Nov 2003 | A1 |
20040033598 | Vacanti et al. | Feb 2004 | A1 |
20040039438 | Alt | Feb 2004 | A1 |
20040054410 | Barrows | Mar 2004 | A1 |
20040057937 | Jahoda et al. | Mar 2004 | A1 |
20040068284 | Barrows | Apr 2004 | A1 |
20040096514 | Vogel | May 2004 | A1 |
Number | Date | Country |
---|---|---|
2140090 | Aug 1995 | CA |
2199918 | Sep 1997 | CA |
0236014 | Sep 1987 | EP |
405656 | Jan 1991 | EP |
1002859 | May 2000 | EP |
971679 | Jun 2002 | EP |
00845963 | Sep 2003 | EP |
1083874 | Jan 2004 | EP |
1089704 | Feb 2004 | EP |
1098626 | May 2004 | EP |
1437042 | Jul 2004 | EP |
3273028 | Dec 1991 | JP |
4-108444 | Apr 1992 | JP |
7-48769 | Feb 1995 | JP |
10-136977 | May 1998 | JP |
2003328229 | Nov 2003 | JP |
WO199962491 | Jun 1998 | WO |
WO 9844027 | Oct 1998 | WO |
WO199847471 | Oct 1998 | WO |
WO 9934750 | Jul 1999 | WO |
WO200003749 | Jul 1999 | WO |
WO 0029553 | May 2000 | WO |
WO 0045736 | Aug 2000 | WO |
WO 0062829 | Oct 2000 | WO |
WO200158413 | Aug 2001 | WO |
WO200166472 | Sep 2001 | WO |
WO200170132 | Sep 2001 | WO |
WO200170289 | Sep 2001 | WO |
WO200170290 | Sep 2001 | WO |
WO200170291 | Sep 2001 | WO |
WO2002060396 | Aug 2002 | WO |
WO2002070728 | Sep 2002 | WO |
WO2003022043 | Mar 2003 | WO |
WO 03104443 | Dec 2003 | WO |
WO2004044188 | May 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20040054410 A1 | Mar 2004 | US |
Number | Date | Country | |
---|---|---|---|
60223636 | Aug 2000 | US |